Clinical Trial Update: Antithrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC) [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update on antithrombotic therapy to reduce complications in COVID-19, spanning Phase 2 and Phase 3, with completed status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumonia

Snippet

Sponsor: University of Manitoba | Conditions: COVID-19, Pneumonia | Phase 2, Phase 3 | Status: COMPLETED